Dietmar Dammerer: How Should We Manage Traumatic Brain Injury When on Anticoagulants?
Dietmar Dammerer, Head of the Department of Orthopedics and Traumatology at the University Hospital Krems, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Archives of Orthopaedic and Trauma Surgery, adding:
”NEW PUBLICATION.
How should we manage patients with mild traumatic brain injury who are taking anticoagulants?
Despite the growing number of patients on antithrombotic therapy presenting to emergency departments after head trauma, clinical practice remains far from uniform.
I’m excited to share our newly published nationwide survey examining how Austrian trauma and neurosurgical departments manage patients with mild traumatic brain injury (mTBI) receiving antiplatelet agents, vitamin K antagonists, or direct oral anticoagulants.
Key findings:
- Nearly all participating departments routinely perform cranial CT scans in anticoagulated patients after mild head injury.
- Significant regional differences exist regarding hospital admission practices, particularly for patients receiving DOACs and those with hemophilia.
- Management strategies vary considerably across Austria, highlighting the absence of up-to-date national guidance.
As healthcare systems face increasing patient volumes and resource constraints, standardized, evidence-based protocols are becoming more important than ever.
Our findings underline a clear opportunity: developing contemporary national guidelines that support both patient safety and efficient resource utilization.
A sincere thank you to all participating departments and colleagues who contributed to this nationwide effort.
The full publication is now available, and I look forward to discussing its implications for trauma care, emergency medicine, neurosurgery, and healthcare policy.”
Title: Regional differences in the management of patients with mild traumatic brain injury and antithrombotic therapy—an Austrian survey
Authors: Barbara Sebek, Dietmar Dammerer, David Putzer, Lukas Moser

Stay updated on all scientific advances with Hemostasis Today.
-
Sep 20, 2026, 13:29Factor XI Deficiency and the Challenge of Unpredictable Bleeding – EHC
-
Sep 20, 2026, 13:18Cindy Howry: FDA Approves First Treatment for Ataxia-Telangiectasia
-
Sep 20, 2026, 13:08Mohammad Salar Amoli: When Routine Coagulation Tests Miss von Willebrand Disease
-
Sep 20, 2026, 12:55Stelios Andreadis։ Human Salivary Gland Organoids Offer New Potential for Regenerative Medicine
-
Sep 20, 2026, 12:43Obi Light Ogbonnia: The Power of Lived Experience in Sickle Cell Care
-
Sep 20, 2026, 12:34Sabrine Mekni: Advancing HSCT for Children With Fanconi Anemia
-
Sep 20, 2026, 12:11Giacomo Buso: Silent Atherosclerosis Begins Earlier Than Expected
-
Sep 20, 2026, 12:0310 Posts Not to Miss This Week
-
Sep 20, 2026, 11:27Edward Lee Carter: Prasugrel Dosing Matters in P2Y12 Inhibitor Comparisons After PCI